Acadia Pharmaceuticals reported $124.93M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 124.93M 14.92M
Adamas Pharmaceuticals ADMS:US 25.32M 3.88M
Alexion Pharmaceuticals ALXN:US $ 1511.1M 71.5M
ALKERMES ALKS:US 244.58M 6.01M
Alnylam Pharmaceuticals ALNY:US $ 154.97M 35.33M
Biogen BIIB:US $ 2267.1M 48.2M
Biomarin Pharmaceutical BMRN:US $ 305.2M 69.43M
Bristol Myers Squibb BMY:US $ 9333M 81M
Corcept Therapeutics CORT:US $ 94.86M 4.65M
Eisai 4523:JP Y 122837M 36807M
Eli Lilly And LLY:US $ 5342M 555.1M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Intercept Pharmaceuticals ICPT:US $ 92.17M 3.79M
Intra Cellular Therapies ITCI:US $ 20.21M 2.2M
Johnson & Johnson JNJ:US $ 16088M 343M
Moderna Inc MRNA:US 4.25B 643M
Neurocrine Biosciences NBIX:US $ 291.8M 6M
Pfizer PFE:US $ 14163M 2178M
Ptc Therapeutics PTCT:US $ 132.2M 22.89M
Sarepta Therapeutics SRPT:US $ 165.96M 21.39M
Seattle Genetics SGEN:US $ 341.41M 31.02M
Ultragenyx Pharmaceutical RARE:US $ 77.47M 6.37M
Vanda Pharmaceuticals VNDA:US $ 63.3M 1.96M
Vertex Pharmaceuticals VRTX:US $ 1747.65M 182.25M
YTE INCY:US $ 778.52M 105.44M
Zogenix ZGNX:US $ 21.32M 3.75M